Interleukins in chronic liver disease: lessons learned from experimental mouse models

References

• BrockerCThompsonDMatsumotoANebertDWVasiliouVEvolutionary divergence and functions of the human interleukin (IL) gene familyHum Genomics20105305521106488
   PubMedGoogle Scholar
• ComminsSPBorishLSteinkeJWImmunologic messenger molecules: cytokines, interferons, and chemokinesJ Allergy Clin Immunol2010125S53S7219932918
   PubMed Web of Science ®Google Scholar
• KarinMLawrenceTNizetVInnate immunity gone awry: linking microbial infections to chronic inflammation and cancerCell200612482383516497591
   PubMed Web of Science ®Google Scholar
• MotzGTCoukosGDeciphering and reversing tumor immune suppressionImmunity201339617323890064
   PubMed Web of Science ®Google Scholar
• JekarlDWLeeSYLeeJProcalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsisDiagn Microbiol Infect Dis20137534234723391607
   PubMed Web of Science ®Google Scholar
• StreetzKLTackeFLeifeldLInterleukin 6/gp130-dependent pathways are protective during chronic liver diseasesHepatology20033821822912830005
   PubMed Web of Science ®Google Scholar
• TackeFLueddeTTrautweinCInflammatory pathways in liver homeostasis and liver injuryClin Rev Allergy Immunol20093641218600481
   PubMed Web of Science ®Google Scholar
• TagaTKishimotoTGp130 and the interleukin-6 family of cytokinesAnnu Rev Immunol1997157978199143707
   PubMed Web of Science ®Google Scholar
• BodeJGNimmesgernASchmitzJLPS and TNFα induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophagesFEBS Lett199946336537010606755
   PubMed Web of Science ®Google Scholar
• ZhangDSunMSamolsDKushnerISTAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6J Biol Chem1996271950395098621622
   PubMed Web of Science ®Google Scholar
• StreetzKLWüstefeldTKleinCLack of gp130 expression in hepatocytes promotes liver injuryGastroenterology200312553254312891556
   PubMed Web of Science ®Google Scholar
• WuestefeldTKleinCStreetzKLLack of gp130 expression results in more bacterial infection and higher mortality during chronic cholestasis in miceHepatology2005421082109016250046
   PubMed Web of Science ®Google Scholar
• KleinCWüstefeldTAssmusUThe IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injuryJ Clin Invest200511586086915761498
   PubMed Web of Science ®Google Scholar
• YehSHChenPJGender disparity of hepatocellular carcinoma: the roles of sex hormonesOncology201078Suppl 117217920616601
   PubMed Web of Science ®Google Scholar
• NauglerWESakuraiTKimSGender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 productionScience200731712112417615358
   PubMed Web of Science ®Google Scholar
• ParkEJLeeJHYuGYDietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expressionCell201014019720820141834
   PubMed Web of Science ®Google Scholar
• OgataHKobayashiTChinenTDeletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesisGastroenterology200613117919316831601
   PubMed Web of Science ®Google Scholar
• KovalovichKDeAngelisRALiWFurthEECilibertoGTaubRIncreased toxin-induced liver injury and fibrosis in interleukin-6-deficient miceHepatology20003114915910613740
   PubMed Web of Science ®Google Scholar
• NasirGAMohsinSKhanMMesenchymal stem cells and interleukin-6 attenuate liver fibrosis in miceJ Transl Med2013117823531302
   PubMed Web of Science ®Google Scholar
• JonesSASchellerJRose-JohnSTherapeutic strategies for the clinical blockade of IL-6/gp130 signalingJ Clin Invest20111213375338321881215
   PubMed Web of Science ®Google Scholar
• Rose-JohnSThe biology of interleukin-6 in the 21st centurySemin Immunol201426124556601
   PubMed Web of Science ®Google Scholar
• GalunERose-JohnSThe regenerative activity of interleukin-6Methods Mol Biol2013982597723456862
   PubMedGoogle Scholar
• BorishLAaronsARumbyrtJCvietusaPNegriJWenzelSInterleukin-10 regulation in normal subjects and patients with asthmaJ Allergy Clin Immunol199697128812968648025
   PubMed Web of Science ®Google Scholar
• Del PreteGDe CarliMAlmerigognaFGiudiziMGBiagiottiRRomagnaniSHuman IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine productionJ Immunol19931503533608419468
   PubMed Web of Science ®Google Scholar
• WanSLeClercJLSchmartzDHepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patientsAm Heart J19971333353399060803
   PubMed Web of Science ®Google Scholar
• ThompsonKMaltbyJFallowfieldJMcAulayMMillward-SadlerHSheronNInterleukin-10 expression and function in experimental murine liver inflammation and fibrosisHepatology199828159716069828224
   PubMed Web of Science ®Google Scholar
• LouisHVan LaethemJLWuWInterleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in miceHepatology199828160716159828225
   PubMed Web of Science ®Google Scholar
• WangSCOhataMSchrumLRippeRATsukamotoHExpression of interleukin-10 by in vitro and in vivo activated hepatic stellate cellsJ Biol Chem19982733023089417080
   PubMed Web of Science ®Google Scholar
• MathurinPXiongSKharbandaKKIL-10 receptor and coreceptor expression in quiescent and activated hepatic stellate cellsAm J Physiol Gastrointest Liver Physiol2002282G9819012016123
   PubMed Web of Science ®Google Scholar
• ReitamoSRemitzATamaiKUittoJInterleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblastsJ Clin Invest199494248924927989607
   PubMed Web of Science ®Google Scholar
• HungKSLeeTHChouWYInterleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in miceBiochem Biophys Res Commun200533632433116126171
   PubMed Web of Science ®Google Scholar
• BlissSKAlcarazAAppletonJAIL-10 prevents liver necrosis during murine infection with Trichinella spiralisJ Immunol20031713142314712960341
   PubMed Web of Science ®Google Scholar
• O’GarraAAraiNThe molecular basis of T helper 1 and T helper 2 cell differentiationTrends Cell Biol20001054255011121747
   PubMed Web of Science ®Google Scholar
• AdachiKTsutsuiHKashiwamuraSPlasmodium berghei infection in mice induces liver injury by an IL-12- and Toll-like receptor/myeloid differentiation factor 88-dependent mechanismJ Immunol20011675928593411698470
   PubMed Web of Science ®Google Scholar
• HoffmannKFCasparPCheeverAWWynnTAIFN-gamma, IL-12, and TNF-alpha are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12J Immunol1998161420142109780194
   PubMed Web of Science ®Google Scholar
• AraujoMIBlissSKSuzukiYAlcarazADenkersEYPearceEJInterleukin-12 promotes pathologic liver changes and death in mice coinfected with Schistosoma mansoni and Toxoplasma gondiiInfect Immun2001691454146211179312
   PubMed Web of Science ®Google Scholar
• SugimotoREnjojiMNakamutaMEffect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cellsLiver Int20052542042815780068
   PubMed Web of Science ®Google Scholar
• ShimamuraTFujisawaTHusainSRKioiMNakajimaAPuriRKNovel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat modelJ Immunol20081814656456518802068
   PubMed Web of Science ®Google Scholar
• ChiaramonteMGDonaldsonDDCheeverAWWynnTAAn IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory responseJ Clin Invest199910477778510491413
   PubMed Web of Science ®Google Scholar
• ChiaramonteMGCheeverAWMalleyJDDonaldsonDDWynnTAStudies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosisHepatology20013427328211481612
   PubMed Web of Science ®Google Scholar
• FallonPGRichardsonEJMcKenzieGJMcKenzieANSchistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agentJ Immunol20001642585259110679097
   PubMed Web of Science ®Google Scholar
• ReimanRMThompsonRWFengCGInterleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activityInfect Immun2006741471147916495517
   PubMed Web of Science ®Google Scholar
• HammerichLHeymannFTackeFRole of IL-17 and Th17 cells in liver diseasesClin Dev Immunol2011201134580321197451
   PubMedGoogle Scholar
• LanRYSalungaTLTsuneyamaKHepatic IL-17 responses in human and murine primary biliary cirrhosisJ Autoimmun200932435119101114
   PubMed Web of Science ®Google Scholar
• LaurenceATatoCMDavidsonTSInterleukin-2 signaling via STAT5 constrains T helper 17 cell generationImmunity20072637138117363300
   PubMed Web of Science ®Google Scholar
• MengFWangKAoyamaTInterleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in miceGastroenterology2012143765. e1776. e322687286
   PubMed Web of Science ®Google Scholar
• ZhengLChuJShiYBone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17Cell Biosci201334624314294
   PubMed Web of Science ®Google Scholar
• TangYBianZZhaoLInterleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver diseaseClin Exp Immunol201116628129021985374
   PubMed Web of Science ®Google Scholar
• MaSChengQCaiYIL-17A produced by γδ T cells promotes tumor growth in hepatocellular carcinomaCancer Res2014741969198224525743
   PubMed Web of Science ®Google Scholar
• HammerichLBangenJMGovaereOChemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosisHepatology20145963064223959575
   PubMed Web of Science ®Google Scholar
• HammerichLTackeFRole of gamma-delta T cells in liver inflammation and fibrosisWorld J Gastrointest Pathophysiol2014510711324891982
   PubMedGoogle Scholar
• WolkKKunzSWitteEFriedrichMAsadullahKSabatRIL-22 increases the innate immunity of tissuesImmunity20042124125415308104
   PubMed Web of Science ®Google Scholar
• RadaevaSSunRPanHNHongFGaoBInterleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activationHepatology2004391332134215122762
   PubMed Web of Science ®Google Scholar
• KiSHParkOZhengMInterleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3Hepatology2010521291130020842630
   PubMed Web of Science ®Google Scholar
• YangLZhangYWangLAmelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22J Hepatol20105333934720452699
   PubMed Web of Science ®Google Scholar
• KongXFengDWangHInterleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in miceHepatology2012561150115922473749
   PubMed Web of Science ®Google Scholar
• FengDKongXWengHInterleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infectionGastroenterology2012143188198. e722484119
   PubMed Web of Science ®Google Scholar
• JiangRTanZDengLInterleukin-22 promotes human hepatocellular carcinoma by activation of STAT3Hepatology20115490090921674558
   PubMed Web of Science ®Google Scholar
• SchmitzJOwyangAOldhamEIL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokinesImmunity20052347949016286016
   PubMed Web of Science ®Google Scholar
• SanadaSHakunoDHigginsLJSchreiterERMcKenzieANLeeRTIL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling systemJ Clin Invest20071171538154917492053
   PubMed Web of Science ®Google Scholar
• MillerAMXuDAsquithDLIL-33 reduces the development of atherosclerosisJ Exp Med200820533934618268038
   PubMed Web of Science ®Google Scholar
• MarviePLisbonneML’Helgoualc’hAInterleukin-33 overexpression is associated with liver fibrosis in mice and humansJ Cell Mol Med2010141726173919508382
   PubMed Web of Science ®Google Scholar
• McHedlidzeTWaldnerMZopfSInterleukin-33-dependent innate lymphoid cells mediate hepatic fibrosisImmunity20133935737123954132
   PubMed Web of Science ®Google Scholar